Fierce Pharma Biopharma News & Insights
WEBFierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader pharma industry, including manufacturing, marketing and finance.
The top 10 most profitable pharma companies in 2021
WEBThe six largest drugmakers by 2021 revenue—J&J, Pfizer, Roche, AbbVie, Novartis and Merck & Co.—all made the top profit list but in quite a different order.
Big Pharma Companies Ranked by Revenue 2022 | Fierce Pharma
WEBApr 18, 2023 · Small revenue declines were registered by Novartis (2%), Bristol Myers Squibb (0.5%) and Gilead Sciences (0.1%). Falling out of the top 20 from last year is Viatris, which saw a 9% revenue decline ...
Pharma | Fierce Pharma
WEBCSL Seqirus, Sanofi and GSK begin flu vaccine shipments in US. The companies started distributing shipments of their respective vaccine options ahead of the fall flu season. Zoey Becker Jul 11 ...
The top 20 pharma companies by 2021 revenue | Fierce Pharma
WEBApr 12, 2022 · Of the world’s top 20 pharmas ranked by 2021 revenues, 12 had at least 10% growth, including five that saw their sales boom at least 40%. No company pulled in more revenue from COVID products ...
Top 20 Pharmaceutical Companies by Revenue 2021 | FiercePharma
WEBMar 29, 2021 · The pharma industry quickly took center stage when COVID-19 caught the world off guard early last year. As 2020 progressed, drugmakers battled the coronavirus on one hand and on the other ...
The top 10 generic drug makers by 2021 revenue - Fierce Pharma
WEBJul 18, 2022 · After a period of stagnant sales largely because of increased competition and pricing pressures, the generic drug industry took another hit during the coronavirus pandemic. In its 10-K annual ...
Novo Nordisk and Novartis put Victoza patent suit to bed, teeing …
WEBMar 23, 2022 · After Teva Pharmaceutical snagged the OK to launch its Victoza generic in 2023, another copycat has secured a launch timeline for its generic to Novo Nordisk’s aging GLP-1 mainstay.
Fierce Biotech News & Reports
WEBApr 15, 2024 · 2024's layoff woes continue in Q2: Fierce Biotech analysis. At least 7,616 workers are known to have been impacted by second quarter layoffs, a stark increase from the 2,398 known in the first ...
Top 10 most anticipated drug launches of 2022 | Fierce Pharma
WEBAfter 55 new drug approvals at the FDA last year, biopharma and the U.S. agency are still going all guns blazing in getting new therapies out to patients. But what are the most hotly tipped—and ...
Skip to content